These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6510257)
1. [Prostaglandins and inhibitors of their synthesis in occlusive vascular diseases]. Viinikka L Duodecim; 1984; 100(16):1007-16. PubMed ID: 6510257 [No Abstract] [Full Text] [Related]
2. An antagonist of prostaglandin synthesis in cardiovascular diseases. Viinikka L Ann Clin Res; 1984; 16(5-6):262-8. PubMed ID: 6398664 [TBL] [Abstract][Full Text] [Related]
7. The translational therapeutics of prostaglandin inhibition in atherothrombosis. Yu Y; Ricciotti E; Grosser T; Fitzgerald GA J Thromb Haemost; 2009 Jul; 7 Suppl 1():222-6. PubMed ID: 19630805 [TBL] [Abstract][Full Text] [Related]
8. Role of sulfur amino acids in the prevention and regression of cardiovascular diseases. Yamori Y; Wang H; Ikeda K; Kihara M; Nara Y; Horie R Prog Clin Biol Res; 1983; 125():103-15. PubMed ID: 6878400 [No Abstract] [Full Text] [Related]
9. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors]. Zettl H; Schubert-Zsilavecz M Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349 [No Abstract] [Full Text] [Related]
10. Prostaglandins, tumor invasiveness and treatment with inhibitors of prostaglandin synthesis. Bennett A Prog Lipid Res; 1981; 20():677-9. PubMed ID: 7342121 [No Abstract] [Full Text] [Related]
11. [The role of prostaglandins in hemostasis and thrombosis]. Maffei FH Arq Bras Cardiol; 1981 Jun; 36(6):427-36. PubMed ID: 7052026 [No Abstract] [Full Text] [Related]
14. [Recommendations for comprehensive risk reduction for patients with coronary heart disease, vascular diseases and diabetes. Distributed by the leadership of the German Society of Cardiology-Heart- and Vascular Research. Produced by request of the Committee of Clinical Cardiology by the Prevention Project Group]. Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G; Z Kardiol; 2002; 91 Suppl 2():61-2. PubMed ID: 12436766 [No Abstract] [Full Text] [Related]
16. [What other effects do statins have except their effect on lipids?]. Tikkanen MJ Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256 [No Abstract] [Full Text] [Related]
17. [Prostanoid synthesis inhibitors in the treatment of menorrhagia]. Presl J Cesk Gynekol; 1982 May; 47(4):284-5. PubMed ID: 7094059 [No Abstract] [Full Text] [Related]
18. A rationale for the treatment of dysmenorrhea. Csapo AI J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020 [TBL] [Abstract][Full Text] [Related]
19. [Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention]. Marshall M Fortschr Med; 1982 May; 100(18):825-30. PubMed ID: 7095698 [TBL] [Abstract][Full Text] [Related]
20. Preclinical ocular evaluation of noncorticosteroidal antiinflammatory agents. Murray DL; Leopold IH Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):201-8. PubMed ID: 6820959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]